Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves

被引:0
|
作者
Okagawa, Tomohiro [1 ]
Konnai, Satoru [1 ,2 ,3 ]
Nakamura, Hayato [2 ]
Ganbaatar, Otgontuya [2 ]
Sajiki, Yamato [2 ]
Watari, Kei [2 ]
Noda, Haruka [4 ]
Honma, Mitsuru [4 ]
Kato, Yukinari [5 ,6 ]
Suzuki, Yasuhiko [1 ,3 ,7 ,8 ]
Maekawa, Naoya [1 ]
Murata, Shiro [1 ,2 ]
Ohashi, Kazuhiko [1 ,2 ,9 ]
机构
[1] Hokkaido Univ, Fac Vet Med, Dept Adv Pharmaceut, Sapporo 0600818, Japan
[2] Hokkaido Univ, Fac Vet Med, Dept Dis Control, Sapporo 0600818, Japan
[3] Hokkaido Univ, Inst Vaccine Res & Dev HU IVReD, Sapporo 0010021, Japan
[4] Snow Brand Seed Co Ltd, Hokkaido Res Stn, Naganuma 0691464, Japan
[5] Tohoku Univ, Dept Antibody Drug Dev, Grad Sch Med, Sendai 9808575, Japan
[6] Tohoku Univ, Dept Mol Pharmacol, Grad Sch Med, Sendai 9808575, Japan
[7] Hokkaido Univ, Int Inst Zoonosis Control, Div Bioresources, Sapporo 0010020, Japan
[8] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo 0010020, Japan
[9] Hokkaido Univ, Fac Vet Med, Int Affairs Off, Sapporo 0600818, Japan
关键词
PD-L1; PD-1; T cell; live attenuated vaccine; immunotherapy; cattle; RESPIRATORY SYNCYTIAL VIRUS; VIRAL-DIARRHEA-VIRUS; IMMUNE-RESPONSE; GAMMA-DELTA; INFECTION; ANTIBODY; IFN; IMMUNOLOGY; EXHAUSTION; CD4;
D O I
10.3390/vaccines11030559
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interactions between programmed death 1 (PD-1) and PD-ligand 1 (PD-L1) cause functional exhaustion of T cells by inducing inhibitory signals, thereby attenuating effector functions of T cells. We have developed an anti-bovine PD-L1 blocking antibody (Ab) and have demonstrated that blockade of the interaction between PD-1 and PD-L1 reactivates T-cell responses in cattle. In the present study, we examined the potential utility of PD-1/PD-L1-targeted immunotherapy in enhancing T-cell responses to vaccination. Calves were inoculated with a hexavalent live-attenuated viral vaccine against bovine respiratory infections in combination with treatment with an anti-PD-L1 Ab. The expression kinetics of PD-1 in T cells and T-cell responses to viral antigens were measured before and after vaccination to evaluate the adjuvant effect of anti-PD-L1 Ab. PD-1 expression was upregulated in vaccinated calves after the administration of a booster vaccination. The activation status of CD4(+), CD8(+), and gamma delta TCR+ T cells was enhanced by the combination of vaccination and PD-L1 blockade. In addition, IFN-gamma responses to viral antigens were increased following combinatorial vaccination with PD-L1 blockade. In conclusion, the blockade of the PD-1/PD-L1 interaction enhances T-cell responses induced by vaccination in cattle, indicating the potential utility of anti-PD-L1 Ab in improving the efficacy of current vaccination programs.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
    Soares, Kevin C.
    Rucki, Agnieszka A.
    Wu, Annie A.
    Olino, Kelly
    Xiao, Qian
    Chai, Yi
    Wamwea, Anthony
    Bigelow, Elaine
    Lutz, Eric
    Liu, Linda
    Yao, Sheng
    Anders, Robert A.
    Laheru, Daniel
    Wolfgang, Christopher L.
    Edil, Barish H.
    Schulick, Richard D.
    Jaffee, Elizabeth M.
    Zheng, Lei
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (01) : 1 - 11
  • [2] PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection
    Watanabe, T.
    Bertoletti, A.
    Tanoto, T. A.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (07) : 453 - 458
  • [3] Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN- production via PD-1/PD-L1 blockade in bovine mycoplasmosis
    Goto, Shinya
    Konnai, Satoru
    Okagawa, Tomohiro
    Nishimori, Asami
    Maekawa, Naoya
    Gondaira, Satoshi
    Higuchi, Hidetoshi
    Koiwa, Masateru
    Tajima, Motoshi
    Kohara, Junko
    Ogasawara, Satoshi
    Kato, Yukinari
    Suzuki, Yasuhiko
    Murata, Shiro
    Ohashi, Kazuhiko
    IMMUNITY INFLAMMATION AND DISEASE, 2017, 5 (03) : 355 - 363
  • [4] Blockade of PD-1/PD-L1 Promotes Adoptive T-Cell Immunotherapy in a Tolerogenic Environment
    Blake, Stephen J. P.
    Ching, Alan L. H.
    Kenna, Tony J.
    Galea, Ryan
    Large, Justin
    Yagita, Hideo
    Steptoe, Raymond J.
    PLOS ONE, 2015, 10 (03):
  • [5] Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade
    Wakita, Daiko
    Iwai, Toshiki
    Harada, Suguru
    Suzuki, Miho
    Yamamoto, Kaname
    Sugimoto, Masamichi
    ANTICANCER RESEARCH, 2019, 39 (04) : 1749 - 1760
  • [6] Modulation of Vaccine-Induced HIV-1-Specific Immune Responses by Co-Electroporation of PD-L1 Encoding DNA
    Tannig, Pierre
    Peter, Antonia Sophia
    Lapuente, Dennis
    Klessing, Stephan
    Damm, Dominik
    Tenbusch, Matthias
    Ueberla, Klaus
    Temchura, Vladimir
    VACCINES, 2020, 8 (01)
  • [7] PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors
    Seifert, Adrian M.
    Zeng, Shan
    Zhang, Jennifer Q.
    Kim, Teresa S.
    Cohen, Noah A.
    Beckman, Michael J.
    Medina, Benjamin D.
    Maltbaek, Joanna H.
    Loo, Jennifer K.
    Crawley, Megan H.
    Rossi, Ferdinand
    Besmer, Peter
    Antonescu, Cristina R.
    DeMatteo, Ronald P.
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 454 - 465
  • [8] Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion
    Alvarez, Maite
    Simonetta, Federico
    Baker, Jeanette
    Morrison, Alyssa R.
    Wenokur, Arlene S.
    Pierini, Antonio
    Berraondo, Pedro
    Negrin, Robert S.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [9] PD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma
    Jalili-Nik, Mohammad
    Soltani, Arash
    Mashkani, Baratali
    Rafatpanah, Houshang
    Hashemy, Seyed Isaac
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
  • [10] Relationship Between PD-L1 Expression and CD8+ T-cell Immune Responses in Hepatocellular Carcinoma
    Huang, Chun-yu
    Wang, Ying
    Luo, Guang-yu
    Han, Feng
    Li, Yong-qiang
    Zhou, Zhong-guo
    Xu, Guo-liang
    JOURNAL OF IMMUNOTHERAPY, 2017, 40 (09) : 323 - 333